Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule

doi:10.3748/wjg.v17.i30.3503

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4693)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-6) series.

Item

Count

PDF

359

HTML

3873

Figures (1-4)

231

Tables (1-6)

230

Sum=4693

Aug 14, 2011 (publication date) through Nov 15, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 14, 2011; 17(30): 3503-3509
Published online Aug 14, 2011. doi: 10.3748/wjg.v17.i30.3503

Full Size Figure Download Figure

Figure 2 A 72-year-old man with well differentiated hepatocellular carcinoma. A: Computed tomography (CT) hepatic arteriography shows faint hypodensity; B: CT during arterial portography shows faint hypodensity; C: The lesion clearly shows hypointensity in the hepatobiliary phase on gadoxetic acid-enhanced magnetic resonance imaging (arrow).

Citation: Saito K, Moriyasu F, Sugimoto K, Nishio R, Saguchi T, Nagao T, Taira J, Akata S, Tokuuye K. Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule. World J Gastroenterol 2011; 17(30): 3503-3509
URL: https://www.wjgnet.com/1007-9327/full/v17/i30/3503.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i30.3503